| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $468.1M | +94.2% |
| Cost of Revenue | $382.2M | +103.8% |
| Gross Profit | $85.9M | +60.5% |
| R&D Expense | $195.0M | +34.4% |
| SG&A Expense | $90.4M | +11.0% |
| Operating Income | -$341.8M | -28.8% |
| Interest Expense | $9.4M | +528.1% |
| Pre-tax Income | -$347.3M | -156.9% |
| Income Tax | -$2.2M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $264.2M | -16.2% |
| Accounts Receivable | $164.9M | +117.1% |
| Inventory | $68.7M | +91.6% |
| Current Assets | $704.2M | +51.7% |
| Total Assets | $1.08B | +26.2% |
| Current Liabilities | $284.3M | +50.4% |
| Long-term Debt | $294.9M | — |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$267.0M | -69.9% |
| Capital Expenditures | $18.6M | +13.1% |
| Investing Cash Flow | -$126.2M | +43.1% |
| Financing Cash Flow | $372.9M | -32.2% |
| Free Cash Flow | -$285.6M | -64.5% |
| +26.0% |
| Net Income | -$345.1M | -161.0% |
| EPS (Basic) | -$1.02 | -1.0% |
| EPS (Diluted) | -$1.02 | +31.5% |
| Total Liabilities |
| $725.0M |
| +134.7% |
| Stockholders' Equity | $355.0M | -35.1% |